Thin-layer chromatographic determination of furosemide and 4-chloro-5-sulfamoyl anthranilic acid in plasma and urine.

B Wesley-Hadzija, A M Mattocks

Index: J. Chromatogr. A. 229(2) , 425-32, (1982)

Full Text: HTML

Related Compounds

The use of HPLC to elucidate the metabolism and urinary excretion of furosemide and its metabolic products.

1981-09-01

[Acta Pharmacol. Toxicol. (Copenh.) 49(3) , 223-9, (1981)]

The binding of furosemide to serum proteins in elderly patients: displacing effect of phenprocoumon.

1980-09-01

[Acta Pharmacol. Toxicol. (Copenh.) 47(3) , 202-7, (1980)]

Furosemide accelerates gentamicin accumulation in cultured renal cells (LLC-PK1 cells).

1989-01-01

[Nephron 53(2) , 138-41, (1989)]

Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.

1980-01-01

[Drug Metab. Dispos. 8(5) , 337-42, (1980)]

The urinary excretion of frusemide and its metabolites by kidney transplant patients.

1987-01-01

[Eur. J. Clin. Pharmacol. 32(3) , 313-5, (1987)]